Skip to main content
letter
. 2020 Oct 1;202(7):1046–1048. doi: 10.1164/rccm.201912-2436LE

Table 1.

Patient Characteristics

Characteristics No PGD (n = 85) PGD (n = 28) P Value
Sex, M 50 (58.8) 15 (53.6) 0.626
       
Age, yr 56.6 ± 12.8 57.0 ± 10.0 0.884
       
Race     0.521
 White 69 (81.2) 19 (67.9)  
 Black 5 (5.9) 3 (10.7)  
 Asian 2 (2.4) 1 (3.6)  
 Hispanic 2 (2.4) 1 (3.6)  
 Other or unknown 7 (8.2) 4 (14.3)  
       
Diagnosis     0.187
 COPD 18 (21.2) 5 (17.9)  
 IPF 30 (35.3) 6 (21.4)  
 Non-IPF ILD 18 (21.2) 10 (35.7)  
 Cystic fibrosis 10 (11.8) 2 (7.1)  
 Bronchiectasis 4 (4.7) 0  
 Sarcoidosis 3 (3.5) 4 (14.3)  
 PAH 1 (1.2) 1 (3.6)  
 Bronchiolitis obliterans 1 (1.2) 0  
       
CMV positive 41 (48.2) 10 (35.7) 0.248
       
BMI 24.8 ± 4.7 26.5 ± 4.7 0.109
       
Pulmonary artery pressure 29.5 ± 15.4 31.2 ± 10.7 0.595
       
LAS 45.0 ± 15.7 47.3 ± 14.0 0.504
       
Bilateral transplant 55 (64.7) 24 (85.7) 0.056
       
Total ischemic time      
 Single 234.9 ± 52.3 241.0 ± 126.6 0.841
 Bilateral 334.8 ± 77.2 364.5 ± 95.5 0.149
       
Donor mode of death     0.675
 Head trauma 29 (34.1) 9 (32.1)  
 Stroke/cerebrovascular 27 (31.8) 12 (42.9)  
 Anoxia 28 (32.9) 7 (25.0)  
 Other 1 (1.2) 0 (0.0)  
       
Donor PaO2 477.2 ± 80.4 475.9 ± 79.7 0.940
       
Donor sex, M 43 (71.7) 17 (28.3) 0.352
       
Donor smoking 40 (47.1) 15 (53.6) 0.550

Definition of abbreviations: BMI = body mass index; CMV = cytomegalovirus; COPD = chronic obstructive pulmonary disease; ILD = interstitial lung disease; IPF = idiopathic pulmonary fibrosis; LAS = Lung Allocation Score; PAH = pulmonary arterial hypertension; PGD = primary graft dysfunction. Data are shown as mean ± SD or n (%).